Skip to content

Compression Is Life In Cardiac Arrest - Quality Study (CILICA-QS)

Impact of a Feedback Device, CPRmeter®, on Chest Compression Quality Preservation During Cardio-pulmonary Resuscitation: A Manikin Study

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03140202
Acronym
CILICA-QS
Enrollment
65
Registered
2017-05-04
Start date
2017-04-18
Completion date
2017-10-01
Last updated
2017-07-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiac Arrest

Brief summary

Context: Chest compressions quality is known to be essential in cardiopulmonary resuscitation. Despite a known harmful effect of chest compressions interruptions, current guidelines still recommend provider switch every 2 minutes. Feedback impact on chest compressions quality preservation during cardiopulmonary resuscitation remains to be assessed. Study design: simulated prospective monocentric randomized crossover trial. Participants and methods: Sixty five professionals rescuers of the pre-hospital care unit of University Hospital of Caen (doctors, nurses and ambulance drivers) are enrolled to performed continuous chest compression on manikin (ResusciAnne®, Laerdal), twice, with and without a feedback device (CPRmeter®). Correct compression score (the main criterion) is defined by reached target of rate, depth and leaning at the same time (recorded continuously). Hypothesis: Feedback device preserve chest compression quality above the 2 minutes recommended switch over during cardiopulmonary resuscitation.

Interventions

DEVICECPRmeter (feedback device) with feedback

Participants have a real time feedback and record.

DEVICECPRmeter (feedback device) without feedback

Participants have a real time record without feedback.

Sponsors

University Hospital, Caen
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
OTHER
Masking
NONE

Intervention model description

In Guide group, participants have a real time feedback (and record) on chest compression quality performed by means of the visuals informations profided by the feedback device. In Blind group, participants have a real time record of chest compression quality performed by means of the feedback device without feedback information of the performance.

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Operational staff of University hospital of Caen pre-hospital unit * Ability in CardioPulmonary Resuscitation

Exclusion criteria

* medical contraindication * refusal

Design outcomes

Primary

MeasureTime frameDescription
Correct compression scoreDay 0Correct compression score is defined by reached target of rate (between 100/min and 120/min), depth (between 50 mm and 60 mm) and leaning (less than 2500g) at the same time

Secondary

MeasureTime frameDescription
Chest compression depthDay 0Chest compression depth reached (in mm)
Chest compression rateDay 0Chest compression rate per min
Percentage of chest compression without leaningDay 0Percentage of chest compression without leaning defined with a residual weight egal or above 2500 g
Decrease time of 30% of correct compression scoreDay 0Time at witch correct compression score decrease of 30% of the reference correct compression score (first 20 secondes)
Percentage of correct chest compression rateDay 0Percentage chest compression rate between 100/min and 120/min
Participants' fatigue (Borg's scale)Day 0Participant auto-evaluation of fatigue with a predefined scale from 6 to 20 (no unit).
Percentage of chest compression with correct depthDay 0Percentage of chest compression with depth between 50 mm and 60 mm

Other

MeasureTime frameDescription
Hemodynamic effect n1 of Cardiopulmonary ResuscitationDay 0Impact of Cardiopulmonary Resuscitation effort on participant blood pressure (mmHg)
Hemodynamic effect n2 of Cardiopulmonary ResuscitationDay 0Impact of Cardiopulmonary Resuscitation effort on participant heart frequency (/min)

Countries

France

Contacts

Primary ContactClement BULEON, MD
buleon-c@chu-caen.fr+(33)231064736

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026